Pfizer/BioNTech vaccine appears effective against mutation in new coronavirus variants — study – The Edge Markets MY

NEW YORK (Jan 8): Pfizer Inc and BioNTech’s Covid-19 vaccine appeared to work against a key mutation in the highly transmissible new variants of the coronavirus discovered in the UK and South Africa, according to a laboratory study conducted by the US drug maker.
The not-yet peer reviewed study by Pfizer and scientists from the University of Texas Medical Branch indicated the vaccine was effective in neutralising virus with the so-called N501Y mutation of the spike protein.
The mutation could be…

Click here to view the original article.